NCT06638307 2026-03-11A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerStemline Therapeutics, Inc.Phase 1 Recruiting240 enrolled
NCT06691035 2025-12-04Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Recruiting18 enrolled